Can monitoring asparaginase activity help us to manage toxicity in pediatric acute lymphoblastic leukemia?

Leuk Lymphoma. 2020 Apr;61(4):990-992. doi: 10.1080/10428194.2019.1691191. Epub 2019 Nov 21.

Authors

Carmen Hernández-Marqués¹, Maitane Andión¹, Marta Perez-Somarriba¹, Luis Madero¹, Alvaro Lassaletta¹

Affiliation

¹ Department of Pediatric Hematology-Oncology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

PMID: 31749392
DOI: 10.1080/10428194.2019.1691191

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents* / adverse effects
Antineoplastic Agents* / therapeutic use
Asparaginase / metabolism*
Child
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy

Substances

Antineoplastic Agents
Asparaginase